Back

The change of paradigm: high HDL-c levels could not mean a long lifespan

30 August 2024 (16:25 - 16:35)
Organised by: Logo
Congress Presentation Part of: Dyslipidaemia: novel diagnostics and therapy options Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Francisco Sousa

Hospital Central do Funchal, Funchal (Portugal)

5 More presentations in this session

Presentation thumbnail
Comparative efficacy of colchicine and intensive LDL-C lowering in patients with ASCVD receiving statins: a network meta-analysis of randomised controlled trials
Doctor Z. Ou (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Deciphering lipoprotein(a) atherogenicity with use of high-throughput proteomics
Doctor J. Morze (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study
Professor D. Nanchen (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study
Doctor S. Brennan (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Dyslipidaemia: novel diagnostics and therapy options
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 16:25 CET
You may be interested in
thumbnail
Congress Presentation
High levels of high-density lipoprotein cholesterol (HDL-C) and major adverse cardiovascular events and 10-year all-cause mortality:results from Women's Ischemia Syndrome Evaluation (WISE) study
thumbnail
Congress Presentation
The high HDL controversy continues: the prognosis for women with a high HDL profile is seriously unfavourable
thumbnail
Congress Presentation
HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources